These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9844862)
1. [Current trends in the therapy of rheumatoid arthritis]. Grishina EI Lik Sprava; 1998 Aug; (6):18-23. PubMed ID: 9844862 [No Abstract] [Full Text] [Related]
3. [Biologics in rheumatology. Targeted therapy--and what must be considered]. Fischer A MMW Fortschr Med; 2010 Sep; 152(38):12. PubMed ID: 20960670 [No Abstract] [Full Text] [Related]
4. [Experimental therapy of rheumatoid arthritis with cytokine antagonists]. Manger B Z Rheumatol; 1995; 54(2):105-9. PubMed ID: 7793156 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy of severe rheumatoid arthritis at an early stage of the disease. Tugwell P; Ortiz Z; Griffith B Schweiz Med Wochenschr Suppl; 1996; 80():20S-21S. PubMed ID: 8795119 [No Abstract] [Full Text] [Related]
6. Current immunotherapy in rheumatoid arthritis. Meier FM; Frerix M; Hermann W; Müller-Ladner U Immunotherapy; 2013 Sep; 5(9):955-74. PubMed ID: 23998731 [TBL] [Abstract][Full Text] [Related]
7. Recent trends in the management of rheumatoid arthritis. Anuradha S; Singh NP J Indian Med Assoc; 1998 Nov; 96(11):345-8. PubMed ID: 10218322 [No Abstract] [Full Text] [Related]
8. Immunological therapies for rheumatoid arthritis. Edwards CJ Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791 [TBL] [Abstract][Full Text] [Related]
9. [Cytokines and mediators as therapeutic approaches]. Lorenz HM; Kalden JR Internist (Berl); 1999 Sep; 40(9):945-50. PubMed ID: 10506334 [No Abstract] [Full Text] [Related]
13. Early intervention in rheumatoid arthritis. Vasanth LC; Paget SA Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):9-10, 15-7. PubMed ID: 17694189 [No Abstract] [Full Text] [Related]
14. New concepts in the treatment of rheumatoid arthritis. Goldbach-Mansky R; Lipsky PE Annu Rev Med; 2003; 54():197-216. PubMed ID: 12359827 [TBL] [Abstract][Full Text] [Related]
15. First-in-class biologic to enter rheumatoid arthritis fray. Garber K Nat Biotechnol; 2005 Nov; 23(11):1323-4. PubMed ID: 16273043 [No Abstract] [Full Text] [Related]
16. Future prospects for anti-cytokine treatment. Feldmann M; Miotla J; Paleolog E; Williams R; Malfait AM; Taylor P; Brennan FM; Maini RN Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i119-22. PubMed ID: 11053102 [TBL] [Abstract][Full Text] [Related]
17. What next for rheumatoid arthritis therapy? Blake SM; Swift BA Curr Opin Pharmacol; 2004 Jun; 4(3):276-80. PubMed ID: 15140420 [TBL] [Abstract][Full Text] [Related]
18. Medical treatment of rheumatoid arthritis. Caldwell JR J Fla Med Assoc; 1995 May; 82(5):343-7. PubMed ID: 7602306 [TBL] [Abstract][Full Text] [Related]
19. Use of prognostic markets to guide biologic therapies for rheumatoid arthritis. D'Arcy CA; Willkens RF J Rheumatol; 2002 Dec; 29(12):2662; author reply 2662-3. PubMed ID: 12465172 [No Abstract] [Full Text] [Related]
20. Immunotherapy and other novel therapies. Trentham DE Curr Opin Rheumatol; 1991 Jun; 3(3):369-72. PubMed ID: 1715732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]